RELEASE: REPS. KHANNA, LUNA, KAPTUR, AND BIGGS INTRODUCE BILL TO CODIFY TRUMP’S EXECUTIVE ORDER TO LOWER PRESCRIPTION DRUG COSTS

Washington, DC —Representatives Ro Khanna (CA-17), Anna Paulina Luna (FL-13), Marcy Kaptur (OH-09), and Andy Biggs (AZ-05) introduced the bipartisan Global Fairness in Drug Pricing Act to codify the core provisions of President Trump’s Executive Order into law—ensuring lasting, enforceable reform that permanently delivers lower prices to Americans.  

Americans pay the highest prescription drug prices in the world — in some cases, up to ten times more than patients in other comparably developed nations for the same exact medications. President Trump’s executive order, while a step forward, could be tied up in the courts and delayed indefinitely without action from Congress. 

“Americans are getting ripped off. It’s deeply unfair that we’re paying significantly more for the same prescription drugs than people in other countries. Pharmaceutical companies are raking in billions while patients are rationing their medications or going into crushing debt to get the prescriptions they need. There is bipartisan outrage, and Congress must come together to act. I’m proud to introduce this bipartisan bill with Reps. Luna, Kaptur, and Biggs to lower prices for Americans,” said Rep. Ro Khanna. 

“For decades, Big Pharma has lined its pockets by ripping off American consumers. Their extraordinarily profitable racket overcharged desperate Americans for life-saving medicine, while charging foreign consumers more reasonable prices. I'm proud to reach across the aisle to codify President Trump's executive order, which put an end to this disgusting practice. Congress must make sure that pharmaceutical companies are never allowed to extort the sick and needy again,” said Rep. Anna Paulina Luna.

"It’s time to stand up to drug companies who are more worried about bolstering profits for their Wall Street investors, than making sure people can afford life-saving medication. The predatory pricing practices of giant, largely faceless, pharmaceutical corporations causes undue burden on Americans just trying their best just to get by. There is no reason my constituents should pay more for their medicine than our Canadian neighbors 59 miles away across our northern border. Our effort to guarantee lowest possible pricing will benefit the well-being of tens of millions of Americans. I’m grateful to Congressman Khanna, Congresswoman Luna, and Congressman Biggs for helping lead this bipartisan effort for the American people who need all the help they can get in lowering their prescription drug costs,” said Rep. Marcy Kaptur (OH-09).  

The Global Fairness in Drug Pricing Act legislation would:

1. Direct HHS to propose rulemaking that imposes most-favored-nation price targets, aligning U.S. drug prices with those in peer countries;
2. Authorize the FDA to consistently grant importation waivers for prescription drugs from countries with strong safety records and lower costs;
3. Empower the FTC and DOJ to investigate and act on anti-competitive practices in the pharmaceutical industry using existing antitrust laws;
4. Facilitate direct-to-consumer access to low-cost drugs at international benchmark prices;
5. Require the Department of Commerce and USTR to assess policies that force Americans to subsidize global R&D or suppress fair pricing abroad.

###